-
ARS Pharmaceuticals (NASDAQ:SPRY) Earns "Outperform" Rating from William Blair
来源: Buzz FX / 22 2月 2025 22:26:17 America/New_York
ARS Pharmaceuticals (NASDAQ:SPRY) Earns "Outperform" Rating from William Blair Written by MarketBeat February 22, 2025 Share Link copied to clipboard. ARS Pharmaceuticals ( NASDAQ:SPRY - Get Free Report ) 's stock had its "outperform" ratin
Read more...